[Mechanism of sideroblastic changes in the bone marrow of alcoholic patients].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to Iu L Shapiro.
Explore the source record for details and available documents.
In 72 epileptic patients the bone marrow was examined in various periods of epileptic paroxysms. It was found that the morphological composition of the medullary hemopoiesis was characterized by a myeloid reaction and a lowered mitotic activity of the bone marrow elements. All the shifts in the functional state of the medullary hemopoiesis correlated with the paroxysm periods and were reflected adequately in the peripheral blood picture. The states described differed sharply from the anomalous medullary hemopoiesis observed in epileptic patients having hematological complications, e.g. pernicious anemia caused by phenobarbital, hexamidine and diphenin.
A study of plasmocellular reactions of the bone marrow in alcoholism and alcoholic psychoses demonstrated an increase in the amount of plasmatic cells, a prevalence of mature plasmatic elements with distinctly marked basophilia and a reaction of clasmatosis. These facts indicate the functional preservation in alcoholism of the system of B cells, the derivatives of which are plasmatical elements; of an increase in the protein synthesis (including antibodies) as well as a prevalence of the so-called productive phase of immunogenesis over the adaptive.
Blood neutrophils were studied in epileptic patients. Differentiation of neutropenia induced by epilepsy from neutropenia due to anticonvulsants enabled one to reveal that incidence of the latter amounts to 6%. Differentiation of drug-induced neutropenia (54 observations) depending on the pathogenetic mechanism or origin (tonic and allergic), features of the blood picture and the nature of the disease course (stable, recurrent, transitory) is of special importance for diagnosis and choice of therapeutic tactics.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Dermatoglyphic alterations in schizophrenic patients are considered in virtue of literature data and the author's own investigations. The absence of obvious and regular difference between healthy people and schizophrenic patients in the incidence of finger and palm patterns is revealed. Only statistically insignificant tendency of different manifestations of some features in patients and healthy persons is observed. Skin patterns doubtly may be used as additional diagnostic paraclinical method and applied to work out genetic aspects of schizophrenia. The addiitonal investigations and particularly and the investigations of "family forms" of schizophrenia are suggested for suggested for complete solution of this problem.
Mutagenic activity of 33 psychotropic drugs was studied in Drosophila metanogaster according to the CLB method. The drugs are the following: leponex, neuleptil, randolectil, teralen, chlorprotixen, TPS-23, navane, pimosid, difenisid, rudotel, eunoktin, radedorm, meprobamat, trioxasin, elenium, napoton, aponal, lorasepam, nuredal, oxyphenonat, safrasin, surmantil, amitriptilin, prothioden, melipramin, saroten, tegretol, phenobarbital, diakarb, benzonal, suksilep, morpholep, sydnocarb. The increase in the mutation rate was induced by leponex (1.37% in adults and 1.21% in larvae), difenisid (1.18% in adults), two forms of the same drug eunoktin and radedorm (about 1.6% in adults), safrasin (1.06% in imago), saroten (1,36% in imago), phenobarbital (2.02% in imago). Even a slight increase of mutagenicity of widely spread psychotropic drugs is a very serious factor which needs further investigation and specification in other models and organisms.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.